Toxoplasmosis in Cats: Risks to Pregnant Women and Infants

Abstract

Toxoplasmosis, caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii, remains a major zoonotic concern worldwide. Domestic cats (Felis catus) and other felids are the definitive hosts, shedding environmentally resistant oocysts that can infect humans and other warm-blooded animals [1, 2]. This review provides a detailed, clinical analysis of feline toxoplasmosis with an emphasis on the transmission risks to pregnant women and infants, referred to herein as cat toxoplasmosis baby risk. The life cycle, epidemiology, clinical manifestations, diagnostic modalities, therapeutic approaches, and preventive strategies are examined using peer-reviewed literature from the past several decades.

Introduction and Etiology

Toxoplasma gondii is a globally distributed protozoan parasite capable of infecting virtually all nucleated cells of homeothermic vertebrates [2, 3]. The parasite exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (contained within tissue cysts), and sporozoites (within oocysts). Felids, particularly domestic cats, are the only hosts that can complete the sexual cycle in the intestinal epithelium and shed oocysts into the environment [2, 4]. Upon ingestion of tissue cysts (e.g., from raw meat) or oocysts, cats develop an enteroepithelial cycle, leading to the excretion of millions of unsporulated oocysts in feces [2, 5]. Once sporulated (1 to 5 days after excretion), oocysts become infective and can persist in soil, water, and on surfaces for months to years [4, 6].

Humans typically acquire infection through ingestion of undercooked meat containing tissue cysts, consumption of food or water contaminated with sporulated oocysts, or accidental ingestion of oocysts from cat feces [4, 7]. Transplacental transmission from an acutely infected pregnant woman to her fetus is the primary mechanism of congenital toxoplasmosis, which can lead to severe neurological and ocular sequelae in the infant [3, 6]. The term cat toxoplasmosis baby encapsulates this critical public health concern.

Epidemiology and Transmission Dynamics

Seroprevalence of T. gondii in cats varies widely by geographic region, husbandry practices, and diagnostic methods. Studies using rapid immunochromatographic tests in Turkey reported a prevalence of 6% [1]. In Brazil, ELISA and indirect immunofluorescence yielded seroprevalences of 15.2% and 7.6%, respectively, in cats from shelters [4]. A study in northeastern Brazil found associated factors including age, outdoor access, and coinfection with feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) [8]. In Pakistan, stray cats exhibited significantly higher infection rates (74.6%) compared to pet cats (25.4%), with older cats (>4 years) showing the highest prevalence [9]. Similarly, in Bangkok, semi-domesticated cats had an 11.5% seroprevalence versus 1.5% in pet cats, and inner-city location increased odds of infection [10]. In Greece, seroprevalence was 20.8%, with older age and history of cat-fight trauma identified as risk factors [11]. A study from Slovakia found 37.4% seroprevalence in owned and shelter cats, highlighting a non-negligible risk of human infection [7].

Oocyst shedding is intermittent and of short duration (1 to 2 weeks) after primary infection, but a single cat can excrete millions of oocysts [2, 4]. Environmental contamination is sustained by stray and feral cats. In Izmir, Turkey, T. gondii DNA was detected in feces of 14.37% of stray cats, and seroprevalence reached 37.84% [12]. In Egypt, a study of household cats found 38.67% overall seropositivity via rapid chromatographic immunoassay, with higher rates in Egyptian Mau breed and cats over one year of age [13]. The risk of oocyst transmission to humans is directly linked to the density of free-roaming cats and the extent of soil and water contamination [7, 12].

Pregnant women who acquire primary toxoplasmosis during gestation can transmit the parasite transplacentally. The risk of fetal infection increases with gestational age, while the severity of sequelae decreases [3, 6]. Cats owned by pregnant women do not inherently increase risk if proper hygiene and litter box management are practiced. However, the presence of a cat shedding oocysts in the household environment constitutes a potential source of infection [7, 12]. The term cat toxoplasmosis baby emphasizes the critical need for education and preventive measures during pregnancy.

Clinical Signs and Pathology in Cats

Most cats infected with T. gondii remain asymptomatic [2, 5]. Clinical toxoplasmosis is relatively rare and is more likely in kittens or immunocompromised adults [14, 15]. In a large case series (100 cats), the most common presentations were generalized toxoplasmosis (36%), pulmonary (26%), abdominal (16%), neurologic (7%), and neonatal (9%) [14]. Fever (73% of cats), dyspnea, polypnea, and abdominal discomfort were frequently observed [14]. Ocular involvement is also common; in the same series, 81.5% of examined eyes had evidence of inflammation, with multifocal iridocyclochoroiditis being the most frequent lesion [14]. Neurological signs include ataxia, circling, seizures, and behavior changes [16, 3].

Neonatal toxoplasmosis in kittens can be devastating. Transplacental or transmammary transmission may result in stillbirth, fading kitten syndrome, or severe multisystemic disease [17, 15]. Two littermate kittens from a shelter in New York succumbed to acute disseminated toxoplasmosis associated with ToxoDB genotype #4, which is common in wildlife [15]. Histopathological lesions are most frequently found in brain, liver, lungs, and pancreas [14, 18]. In pregnant queens, primary infection can lead to abortion or neonatal death [3, 6].

T. gondii genotype may influence clinical severity. The Chinese 1 genotype (ToxoDB #9) has been epidemiologically linked to outbreaks in pigs and humans in China and is widely prevalent in cats in that region [2]. Genotype #4 was identified in the fatal kitten cases in New York [15]. Understanding genotype distribution is important for assessing zoonotic risk.

Diagnostic Approaches

Accurate diagnosis of feline toxoplasmosis is critical for both clinical management and public health risk assessment. Multiple serological and molecular methods are available.

Serological tests detect anti-T. gondii IgG and IgM antibodies. The modified agglutination test (MAT) using formalin-preserved tachyzoites is highly sensitive and yields high titers for more than two years post infection [19]. The Sabin-Feldman dye test was historically used but requires live parasites [19]. ELISA-based assays are widely employed for serosurveys; recombinant antigens including SAG2, GRA6, and GRA7 have been compared, with GRA7 showing the highest sensitivity in cats [20]. Indirect immunofluorescence antibody testing (IFAT) is also commonly used [11]. Immunochromatographic rapid test kits (ICTs) offer point-of-care detection of IgG and IgM and have demonstrated utility in field settings [1, 13]. In a study from Pakistan, ELISA detected IgG and IgM and PCR amplified T. gondii DNA [9].

Molecular diagnostics such as conventional PCR and real-time PCR target the B1 gene or 529 bp repeat element and are used to detect parasite DNA in blood, feces, or tissue samples. PCR on feces is more sensitive than microscopy for detecting oocyst shedding [12]. Real-time PCR allows quantification and can distinguish acute from chronic infection when combined with serology.

Microscopy for oocysts in feces using flotation techniques is specific but insensitive; sensitivity is low because shedding is intermittent and oocysts are small (10–12 μm) [1, 21]. In a study in Egypt, T. gondii oocysts were shed by only 0.43% of stray cats, while DNA was detected in 14.37% [12].

Diagnostic algorithm (see Figure 1) for assessing risk in pregnant women with cat exposure should include testing of the cat (serology and fecal PCR) and testing of the woman (serology for IgG/IgM). Negative serology in the woman indicates susceptibility; positive IgM requires follow-up with IgG avidity to estimate timing of infection [3]. The cat's oocyst shedding status, if positive, increases environmental risk and warrants strict hygiene measures.

flowchart TD
    A[Pregnant woman owns/handles cat], > B{Test cat for T. gondii}
    B, > C[Serology: IgG/IgM]
    B, > D[Fecal PCR/oocyst exam]
    C, > E[Cat seropositive: past exposure]
    C, > F[Cat seronegative: susceptible]
    D, > G[Cat shedding oocysts?]
    G, >|Yes| H[High environmental contamination risk]
    G, >|No| I[Low risk from cat feces]
    H, > J[Recommend strict hygiene: daily litter change, glove use, handwashing]
    E, > J
    F, > J
    A, > K[Test pregnant woman: IgG/IgM]
    K, > L[Woman seronegative: Educate on prevention]
    K, > M[Woman IgM positive: Refer to human medicine for avidity and follow-up]
    L, > J
    M, > N[Potential congenital infection risk]
    style H fill:#f9f,stroke:#333,stroke-width:2px
    style N fill:#f96,stroke:#333,stroke-width:4px

Table 1. Comparison of diagnostic methods for toxoplasmosis in cats

Treatment and Management

Treatment of clinical toxoplasmosis in cats is primarily aimed at reducing tachyzoite multiplication. Clindamycin (10–20 mg/kg orally twice daily for 2–4 weeks) is the most commonly used antibiotic [22, 3]. However, a paradoxical effect has been observed in experimental acute toxoplasmosis, where clindamycin alone may not completely eliminate infection [22]. In Pallas' cats (Otocolobus manul), prophylactic clindamycin reduced first-year mortality from toxoplasmosis by 67% [23]. Other drugs include trimethoprim-sulfonamide combinations, pyrimethamine combined with a sulfonamide, and toltrazuril [3]. Supportive care (fluid therapy, nutritional support, and anti-inflammatory doses of corticosteroids for ocular inflammation) is often needed.

Importantly, treatment does not eliminate the bradyzoite stage; latent infection persists for life. Cats that have recovered from clinical toxoplasmosis should be considered immune to oocyst shedding upon reinfection [24, 25]. However, immunosuppression (e.g., glucocorticoids or concurrent FIV/FeLV infection) can lead to reactivation and renewed shedding [8, 3].

A live attenuated vaccine (RHΔompdcΔuprt) has been developed using CRISPR-Cas9 gene editing in T. gondii. This mutant strain demonstrated attenuated virulence in mice and cats, induced high levels of IgG, IFN-γ, IL-4, IL-10, and CD8⁺ T cell responses, and reduced oocyst shedding by 95.3% in vaccinated cats after challenge [26]. This represents a promising candidate for controlling environmental contamination, but it is not yet commercially available.

Prevention and Control: Cat Toxoplasmosis Baby

Preventing congenital toxoplasmosis requires a combination of veterinary and public health measures. For pregnant women who own cats or have cat toxoplasmosis baby concerns, the following strategies are recommended:

For the cat: Keep the cat indoors to prevent hunting of intermediate hosts (rodents, birds) and ingestion of raw meat [5, 10]. Feed only commercial cooked or processed cat food. Do not allow the cat to roam or scavenge. If the cat is already seropositive (IgG positive), it is unlikely to be shedding oocysts unless recently infected or immunosuppressed [2, 19]. Fecal PCR can confirm current shedding. If shedding is detected, the cat should be isolated during the oocyst excretion period (usually 1–2 weeks) and the litter changed daily while wearing gloves; oocysts require 1–5 days to sporulate, so daily removal prevents infectivity [2, 25].

For the pregnant woman: Avoid handling cat litter if possible; if she must, wear disposable gloves and wash hands thoroughly. Keep litter boxes clean (daily scoop). Cover sandboxes to prevent cat defecation. Wear gloves when gardening. Wash all fruits and vegetables thoroughly. Cook meat to safe internal temperatures. Avoid raw or undercooked meat, especially pork, lamb, and game [4, 6].

Environmental control: Stray cat populations should be managed through trap-neuter-return programs and public education [1, 7, 12]. Oocysts are resistant to most disinfectants but can be inactivated by heating to 70°C for 10 minutes or by incineration [2, 6].

Public health surveillance: Cats can serve as sentinel species for environmental contamination with T. gondii [7]. Monitoring seroprevalence in cats can indicate areas of high risk for human toxoplasmosis. In Bangladesh, a recent review highlighted the neglect of toxoplasmosis as a zoonotic disease and the need for integrated One Health approaches [6].

Conclusion

Toxoplasmosis remains a global zoonotic threat, with cats serving as the definitive host responsible for environmental contamination with T. gondii oocysts. The risk to pregnant women and infants (cat toxoplasmosis baby) is well established and requires a multifaceted prevention strategy combining veterinary diagnostics (serology and fecal PCR), client education, cat management (indoor confinement, commercial diet), and strict hygiene protocols. Advances in molecular diagnostics, including PCR and recombinant antigen ELISAs, have improved detection of active infection and shedding. Emerging live attenuated vaccines hold promise for reducing oocyst output at the population level. Continued surveillance in cat populations is essential to inform public health interventions and protect susceptible populations, particularly pregnant women and their developing fetuses.

References

[1] Parlatır Y, Şenel Y, Kara E. Determination of the prevalence of toxoplasmosis in cats with immunochromatographic rapid tests kits in Kırıkkale University Veterinary Faculty Animal Hospital. Research and Practice in Veterinary and Animal Science. 2025.

[2] Dubey JP, Cerqueira-Cézar CK, Murata F, et al. All about toxoplasmosis in cats: the last decade. Veterinary Parasitology. 2020.

[3] Calero-Bernal R, Gennari SM. Clinical toxoplasmosis in dogs and cats: an update. Frontiers in Veterinary Science. 2019.

[4] Fux B, Covre K, Lopes R, et al. Seroprevalence of toxoplasmosis in cats in Espirito Santo State, Brazil. Current Developments in Nutrition. 2020.

[5] Dubey JP. Toxoplasmosis in cats. Journal. 1986.

[6] Hasan MF, Harun A, Hossain D, et al. Toxoplasmosis in animals and humans: a neglected zoonotic disease in Bangladesh. Journal of Parasitic Diseases. 2024.

[7] Selyemová D, Antolová D, Mangová B, et al. Cats as a sentinel species for human infectious diseases – toxoplasmosis, trichinellosis, and COVID-19. Current Research in Parasitology and Vector-Borne Diseases. 2024.

[8] Munhoz AD, Hage SB, Cruz R, et al. Toxoplasmosis in cats in northeastern Brazil: Frequency, associated factors and coinfection with Neospora caninum, feline immunodeficiency virus and feline leukemia virus. Veterinary Parasitology: Regional Studies and Reports. 2017.

[9] Majid A, Ahmad N, Haleem S, et al. Detection of toxoplasmosis in pets and stray cats through molecular and serological techniques in Khyber Pakhtunkhwa, Pakistan. BMC Veterinary Research. 2021.

[10] Inpankaew T, Sattasathuchana P, Kengradomkij C, et al. Prevalence of toxoplasmosis in semi-domesticated and pet cats within and around Bangkok, Thailand. BMC Veterinary Research. 2021.

[11] Kokkinaki KG, Saridomichelakis M, Mylonakis M, et al. Seroprevalence of and risk factors for Toxoplasma gondii infection in cats from Greece. Animals. 2023. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[12] Karakavuk M, Can H, Selim N, et al. Investigation of the role of stray cats for transmission of toxoplasmosis to humans and animals living in İzmir, Turkey. Journal of Infection in Developing Countries. 2021.

[13] Awad R, Barakat A. Serological diagnosis of toxoplasmosis in household cats in Egypt. Egyptian Journal of Veterinary Sciences. 2019.

[14] Dubey JP, Carpenter JL. Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association. 1993.

[15] Crouch EEV, Mittel L, Southard T, et al. Littermate cats rescued from a shelter succumbed to acute, primary toxoplasmosis associated with TOXO DB genotype #4, generally circulating in wildlife. Parasitology International. 2019.

[16] Cucos C, Ionascu I, Mocanu J, et al. Neurological and ocular form of toxoplasmosis in cats. Journal. 2015.

[17] Dubey JP, Mattix ME, Lipscomb TP. Lesions of neonatally induced toxoplasmosis in cats. Veterinary Pathology. 1996.

[18] Al-Kappany YM, Rajendran C, Ferreira LR, et al. High prevalence of toxoplasmosis in cats from Egypt: Isolation of viable Toxoplasma gondii, tissue distribution, and isolate designation. Journal of Parasitology. 2010.

[19] Dubey JP, Thulliez P. Serologic diagnosis of toxoplasmosis in cats fed Toxoplasma gondii tissue cysts. Journal of the American Veterinary Medical Association. 1989.

[20] Sabukunze S, Gu H, Zhao L, et al. Comparison of the performance of SAG2, GRA6, and GRA7 for serological diagnosis of Toxoplasma gondii infection in cats. Frontiers in Veterinary Science. 2024.

[21] Zakaria R, Ardiansyah S. Potential analysis of toxoplasmosis distribution in wild cats (Felis silvestris) in some markets of Sidoarjo District through microscopic identification of Toxoplasma gondii. Medicra (Journal of Medical Laboratory Science/Technology). 2020.

[22] Davidson MG, Lappin MR, Rottman JR, et al. Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats. Antimicrobial Agents and Chemotherapy. 1996.

[23] Girling S, Pizzi R, Naylor A, et al. Use of clindamycin in Pallas' cats (Otocolobus [Felis] manul) to reduce juvenile toxoplasmosis-associated mortality rates. Journal of Zoo and Wildlife Medicine. 2020.

[24] Dubey JP, Hoover EA, Walls KW. Effect of age and sex on the acquisition of immunity to toxoplasmosis in cats. The Journal of Protozoology. 1977.

[25] Frenkel JK. Toxoplasmosis in cats: diagnosis, treatment and prevention. Comparative Immunology, Microbiology & Infectious Diseases. 1978.

[26] Shen Y, Zheng B, Sun H, et al. A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats. Infectious Diseases of Poverty. 2023.

[27] Ahmad N, Ahmed H, Irum S, et al. Seroprevalence of IgG and IgM antibodies and associated risk factors for toxoplasmosis in cats and dogs from sub-tropical arid parts of Pakistan. Tropical Biomedicine. 2014.

[28] Dubey JP, Frenkel JK. Cyst-induced toxoplasmosis in cats. The Journal of Protozoology. 1972.

[29] Shahzad A, Khan MS, Ashraf K, et al. Sero-epidemiological and haematological studies on toxoplasmosis in cats, dogs and their owners in Lahore, Pakistan. Journal. 2006.

[30] Vainisi SJ, Campbell LH. Ocular toxoplasmosis in cats. Journal. 1969.

[31] Zafar Z, Ali N, Baleanu D. Dynamics and numerical investigations of a fractional-order model of toxoplasmosis in the population of human and cats. Journal. 2021.

[32] Germano PM, Melo H, Bianchin I, et al. Toxoplasmosis in cats and dogs. Journal. 1980.

[33] Bastan I. Clinical and some laboratory findings in cats with toxoplasmosis. Journal. 2018.

[34] Vinogradov LI. Diagnosis of toxoplasmosis in cats. Journal. 1980.

[35] Dubey JP, Lehmann T, Lautner F, et al. Toxoplasmosis in sentinel chickens (Gallus domesticus) in New England farms: seroconversion, distribution of tissue cysts in brain, heart, and skeletal muscle by bioassay in mice and cats. Veterinary Parasitology. 2015.